Authors: Yang, Chunhua; Huang, Feng

Source: Current Rheumatology Reviews, Volume 4, Number 2, May 2008 , pp. 131-134(4)

Publisher: Bentham Science Publishers

Abstract:

Spondyloarthropathy (SpA) comprises a family of chronic inflammatory arthritis disorders, and ankylosing spondylitis (AS) is regarded as the most frequent and severe subtype of SpA. The prevalence of SpA in Chinese is about 0.2-0.3%. Information about the management of SpA is limited in Asian countries. Non-steroidal anti-inflammatory drugs (NSAIDs) are still the medication of choice for relieving the spinal pain and morning stiffness of SpA. Traditional NSAIDs are relatively cheap and more readily available than selective COX-2 inhibitors in Asian countries. Diseasemodifying agents widely used in SpA include sulfasalazine (SSZ), thalidomide, methotrexate (MTX) and leflunomide. SSZ and MTX are the most frequently used in patients with SpA, even though there are few clinical trials to verify their efficacy. Thalidomide is potentially useful in treating severe and refractory AS patients. Tumor necrosis factor (TNF) inhibitors have been shown to be effective in the treatment of AS, but more attention needs to be given to potential tuberculosis (TB) infection. Traditional herbal medicine and acupuncture are also used in relieving pain and improving function in SpA patients in some Asian countries. This review will discuss the current therapeutic strategies for SpA.

Keywords: Management; spondyloarthropathy; ankylosing spondylitis; Asia

Document Type: Research article

DOI: http://dx.doi.org/10.2174/157339708784310293

Publication date: 2008-05-01

More about this publication?

• Current Rheumatology Reviews publishes frontier reviews on all the latest advances on rheumatology and its related areas e.g. pharmacology, pathogenesis, epidemiology, clinical care, and therapy. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field.
  
  The journal is essential reading for all researchers and clinicians in rheumatology.

Related content

• In this: publication
• By this: publisher
• In this Subject: Allergy & Immunology ,  Internal Medicine ,  Pediatrics
• By this author: Yang, Chunhua ;  Huang, Feng

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers